Authors: Fuchtenbusch, M Standl, E Schatz, H

Citation: M. Fuchtenbusch et al., Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus, EXP CL E D, 108(3), 2000, pp. 151-163

Authors: Hummel, M Fuchtenbusch, M Schenker, M Ziegler, AG

Citation: M. Hummel et al., No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB study, DIABET CARE, 23(7), 2000, pp. 969-974

Authors: Fuchtenbusch, M Kredel, K Bonifacio, E Schnell, O Ziegler, AG

Citation: M. Fuchtenbusch et al., Exposure to exogenous insulin promotes IgG1 and the T-Helper 2-associated IgG4 responses to insulin but not to other islet autoantigens, DIABETES, 49(6), 2000, pp. 918-925

Authors: Standl, E Baumgartl, HJ Fuchtenbusch, M Stemplinger, J

Citation: E. Standl et al., Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy, DIABET OB M, 1(4), 1999, pp. 215-220

Authors: Bonifacio, E Scirpoli, M Kredel, K Fuchtenbusch, M Ziegler, AG

Citation: E. Bonifacio et al., Early autoantibody responses in prediabetes are IgG1 dominated and suggestantigen-specific regulation, J IMMUNOL, 163(1), 1999, pp. 525-532